Dr. Eleanor Vance
Biography
Dr. Eleanor Vance is a leading researcher in clinical genetics and cancer immunotherapies. She leads the genomic sequencing division at the iMedipedia Institute, focusing on CRISPR therapeutics and personalized vaccines.
Research Interests
Published Articles
Understanding Renal Tubular Acidosis (RTA) for Internal Medicine Boards
A comprehensive educational breakdown comparing Type 1, Type 2, and Type 4 renal tubular acidosis including diagnostic flowcharts.
Breakthrough Immunotherapy for Glioblastoma
A clinical trial demonstrates that a novel personalized mRNA-based vaccine triggers a strong immune response against glioblastoma, extending survivability in trial patients.
CRISPR-Cas9 Gene Therapy Cure for Sickle Cell Disease
A comprehensive look at the clinical validation of exagamglogene autotemcel, the first CRISPR-based gene editing therapy approved for sickle cell disease.
mRNA Cancer Vaccine Shows Promising Results in Phase II Trials
A detailed review of the phase II clinical trials evaluating personalized mRNA-4157 cancer vaccines combined with pembrolizumab for high-risk melanoma.
Nanoparticle Drug Delivery System Passes Phase I Safety Trials
Review of polymeric nanoparticle vehicle safety data in targeted chemotherapeutic delivery for metastatic breast cancer.
Pediatric Immunization Updates and High-Yield Board Cases
Review of key immunization guidelines, catch-up schedules, and common vaccine contraindications tested on pediatrics licensing exams.